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General Information. Reactions were performed in oven-dried glassware under normal atmosphere (unless 
otherwise specified). All chemical reagents were purchased from commercial suppliers and used without further 
purification. Anhydrous solvents were either purchased from commercial suppliers or obtained from a solvent 
purification system in which solvent was passed through two columns of activated alumina under nitrogen. 
Reactions were monitored by thin-layer chromatography (TLC) on 0.25 mm Analtech GHLF silica gel plates and 
visualized by UV (254 nm). Flash column chromatography was performed on a CombiFlash NextGen 300+ 
purification system (Teledyne Isco) using prepacked RediSepRf silica columns. 1H and 13C NMR were recorded 
on a 400 MHz Varian spectrometer. Chemical shifts (δ) are reported in ppm and referenced with respect to 
residual solvent: CDCl3 at 7.26 ppm, MeOD at 3.31 ppm (1H NMR); CDCl3 at 77.16 ppm, MeOD at 49.00 ppm 
(13C NMR). Coupling constants (J) are reported in Hz. High-resolution mass spectra (HRMS) were obtained on 
an Agilent 6230 time-of-flight mass spectrometer with an electrospray ion source in positive mode. Compounds 
were identified as ≥ 95% pure by HPLC on an Agilent 1260 Infinity II with diode array detection at 214 nm. A 
Poroshell 120 EC-C18 column (4.6 × 100 mm, 2.7 µm) with a gradient mobile phase of 5-100% acetonitrile / 
0.1% phosphoric acid in water was utilized.  
General Procedure for the Formation of Oxalate Salt. Free base compounds were dissolved in MeOH, 
followed by the addition of oxalic acid (1 equiv). Once in solution, MeOH was removed in vacuo and diethyl ether 
added, upon which the oxalate salt precipitated out of solution. The precipitate was collected via vacuum filtration 
and dried under vacuum to afford the corresponding oxalate salt. 
(4aS,7aR,12bS)-9-((tert-butyldimethylsilyl)oxy)-3-(cyclopropylmethyl)-7-oxo-1,2,3,4,5,6,7,7a-octahydro-
4aH-4,12-methanobenzofuro[3,2-e]isoquinolin-4a-yl propionate (36). To a solution of (4aS,7aR,12bS)-9-
((tert-butyldimethylsilyl)oxy)-3-(cyclopropylmethyl)-4a-hydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-
methanobenzofuro [3,2-e]isoquinolin-7(7aH)-one (365 mg, 0.801 mmol) in toluene (10 
mL) was added Et3N (0.167 mL, 1.202 mmol) and propionic anhydride (0.155 mL, 1.202 
mmol). The reaction stirred at reflux for 16 h. The resulting solution was cooled to room 
temperature and washed with sat. aq. NaHCO3 (2 × 15 mL) and water (1 × 15 mL). The 
organic layer was dried over Na2SO4, filtered, and concentrated. The resulting residue 
was purified by column chromatography (0-20% EtOAc/Hexanes) to afford 36 (280 mg, 
0.547 mmol, 68.3%) as a yellow solid. 1H NMR (400 MHz, CDCl3) δ 6.64 (d, J = 8.1 Hz, 
1H), 6.55 (d, J = 8.1 Hz, 1H), 4.59 (s, 1H), 4.45 (d, J = 5.6 Hz, 1H), 3.07 (d, J = 18.6 Hz, 1H), 2.83 (ddd, J = 14.3, 
5.5, 2.8 Hz, 1H), 2.70 (dd, J = 11.9, 5.0 Hz, 1H), 2.61 (td, J = 15.0, 5.3 Hz, 1H), 2.54 – 2.42 (m, 4H), 2.38 – 2.22 
(m, 3H), 2.13 (td, J = 12.0, 3.7 Hz, 1H), 1.66 (td, J = 14.4, 4.0 Hz, 1H), 1.48 (dd, J = 12.4, 3.7 Hz, 1H), 1.22 (td, 
J = 7.6, 1.0 Hz, 3H), 1.00 (s, 9H), 0.76 (m, 1H), 0.48 (m, 2H), 0.26 (s, 3H), 0.19 (s, 3H), 0.08 (m, 2H). 13C NMR 
(100 MHz, CDCl3) δ 207.24, 173.67, 146.91, 138.13, 128.78, 126.44, 122.64, 119.42, 89.67, 82.29, 59.58, 55.78, 
51.09, 44.00, 35.78, 30.45, 28.90, 27.07, 25.85 (3C), 23.37, 18.39, 9.61, 9.55, 3.97, 3.86, –4.39, –4.56.  
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-9-hydroxy-7-oxo-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-
methanobenzofuro[3,2-e]isoquinolin-4a-yl propionate (14). To a solution of 36 (260 mg, 0.508 mmol) in 
CH2Cl2 (1.0 mL) was added KF (74 mg) and MeOH (10 mL). After stirring at room 
temperature for 16 h, the reaction was concentrated and purified by column 
chromatography (30-40% EtOAc/Hexanes) to afford 14 (93 mg, 0.234 mmol, 46.1%). 1H 
NMR (400 MHz, CDCl3) δ 6.73 (d, J = 8.1 Hz, 1H), 6.60 (d, J = 8.3 Hz, 1H), 5.73 (bs, 1H), 
4.70 (d, J = 2.3 Hz, 1H), 4.45 (m, 1H), 3.08 (d, J = 18.4 Hz, 1H), 2.85 (m, 1H), 2.74 – 2.41 
(m, 6H), 2.30 (m, 3H), 2.16 (m, 1H), 1.65 (t, J = 14.3 Hz, 1H), 1.52 (m, 1H), 1.23 (td, J = 
7.6, 2.4 Hz, 3H), 0.76 (m, 1H), 0.49 (m, 2H), 0.07 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 
208.55, 173.61, 143.50, 138.70, 128.34, 125.55, 120.09, 117.92, 90.45, 82.25, 59.64, 55.83, 51.48, 44.00, 35.89, 
30.30, 28.90, 27.18, 23.26, 9.67, 9.55, 4.01, 3.82. HRMS calculated for C23H27NO5 [M+H]+: 398.1959 (found); 
398.1962 (calcd). HPLC purity: > 99%. 
S2
(4a'S,7a'R,12b'S)-9'-(benzyloxy)-4a'-(((E)-3-cyclohexylallyl)oxy)-3'-(cyclopropylmethyl)-2',3',4',4a',5',6'-
hexahydro-1'H,7a'H-spiro[[1,3]dioxolane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinoline] (32b). To a 
solution of (4a'S,7a'R,12b'S)-9'-(benzyloxy)-3'-(cyclopropylmethyl)-1',2',3',4',5',6'-
hexahydro-4a'H,7a'H-spiro[[1,3]dioxolane-2,7'-[4,12]methanobenzofuro[3,2-
e]isoquinolin]-4a'-ol (400 mg, 0.841 mmol) in DMF (8.0 mL) was added NaH (81 mg,
3.364 mmol) (60% dispersion in mineral oil). The reaction mixture was stirred at room
temperature for 10 minutes, followed by the addition of (3-bromoprop-1-en-1-
yl)cyclohexane (480 mg, 2.363 mmol). After stirring at room temperature for 16 h, the
reaction mixture was diluted with EtOAc (20 mL) and poured into sat. aq. NaHCO3 (30
mL). The organic layer was collected, and the aqueous layer extracted with EtOAc (2 ×
20 mL). The combined organic extracts were dried over Na2SO4, filtered, and
concentrated. The resulting residue was purified by column chromatography (0-15% EtOAc/Hexanes) to afford 
32b (85 mg, 0.142 mmol, 16.9%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.43 (m, 2H), 7.35 (m, 2H), 7.30 
(m, 1H), 6.75 (d, J = 8.2 Hz, 1H), 6.54 (d, J = 8.1 Hz, 1H), 5.59 (m, 2H), 5.19 (d, J = 11.9 Hz, 1H), 5.11 (d, J = 
11.9 Hz, 1H), 4.63 (s, 1H), 4.17 (m, 1H), 4.06 (m, 1H), 3.89 (m, 1H), 3.77 (m, 2H), 3.45 (d, J = 4.9 Hz, 1H), 3.08 
(d, J = 18.1 Hz, 1H), 2.65 (dd, J = 11.5, 5.2 Hz, 1H), 2.57 (td, J = 11.9, 5.2 Hz, 1H), 2.35 (m, 3H), 2.19 (td, J =  
13.5, 2.9 Hz, 1H), 2.07 (m, 1H), 1.96 (m, 1H), 1.74 (m, 6H), 1.65 (m, 2H), 1.40 (dt, J = 13.2, 3.3 Hz, 1H), 1.31 
(m, 1H), 1.27 (m, 2H), 1.17 (m, 1H), 1.09 (m, 2H), 0.86 (m, 1H), 0.48 (m, 2H), 0.12 (m, 2H). 13C NMR (100 MHz, 
CDCl3) δ 138.96, 138.25, 128.57 (2C), 127.89, 127.57 (2C), 126.44, 125.30, 118.12, 115.86, 109.30, 94.18, 
75.49, 61.01, 59.65, 56.13, 52.35, 45.15, 40.51 (2C), 38.52, 33.69, 33.39, 33.02, 32.96, 28.96, 26.94, 26.33, 
26.26 (2C), 26.12 (2C), 23.64, 23.16, 9.61, 4.02, 3.82. 
(4R,4aS,7aR,12bS)-4a-(3-cyclohexylpropoxy)-3-(cyclopropylmethyl)-9-hydroxy-2,3,4,4a,5,6-hexahydro-
1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one (16). To a solution of 32b (50 mg, 0.084 mmol) in 
THF (4.0 mL) was added Palladium on Carbon (5 wt. % loading) (50 mg). The reaction flask 
was capped with a rubber septum and flushed with H2. The reaction stirred at room 
temperature under an H2 balloon for 16 h. The reaction mixture was then filtered through 
Celite, rinsing with EtOAc, and concentrated to afford crude 33. Crude 33 was dissolved in 
MeOH (2.0 mL) and conc. HCl (1.5 mL) and stirred at reflux for 4 h. Upon cooling to room 
temperature, the solution was diluted with water and treated with 5 N NaOH / solid NH4Cl 
until pH = 8. The product was then extracted using EtOAc (3 × 10 mL). The combined 
organic extracts were dried over Na2SO4, filtered, and concentrated. The resulting residue 
was purified by column chromatography (0-30% EtOAc/Hexanes) to afford 16 (20 mg, 0.043 
mmol, 51.2% over 2 steps) as a light brown solid. 1H NMR (400 MHz, CDCl3) δ 6.69 (d, J = 8.1 Hz, 1H), 6.56 (d, 
J = 8.1 Hz, 1H), 4.66 (s, 1H), 3.71 (q, J = 7.0 Hz, 1H), 3.52 (m, 1H), 3.29 (q, J = 6.4 Hz, 1H), 3.11 (d, J = 18.3 
Hz, 1H), 2.83 (td, J = 14.4, 5.2 Hz, 1H), 2.73 – 2.64 (m, 2H), 2.38 – 2.37 (m, 3H), 2.18 (dt, J = 14.7, 3.2 Hz, 1H), 
2.12 – 2.01 (m, 2H), 1.77 – 1.61 (m, 7H), 1.43 (m, 2H), 1.33 (m, 4H), 1.19 (m, 3H), 0.86 (m, 2H), 0.51 (m, 2H), 
0.13 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 210.35, 143.61, 138.76, 129.69, 125.48, 119.88, 117.58, 90.88, 
75.28, 60.24, 59.72, 56.10, 51.43, 44.70, 37.66, 35.87, 34.43, 33.65, 33.58, 29.48, 27.77, 26.86 (2C), 26.60 
(2C), 25.94, 23.16, 9.50, 3.96. HRMS calculated for C29H39NO4 [M+H]+: 466.2959 (found); 466.2952 (calcd). 
HPLC purity: > 99%. 
(4a'S,7a'R,12b'S)-9'-(benzyloxy)-3'-(cyclopropylmethyl)-4a'-propoxy-2',3',4',4a',5',6'-hexahydro-1'H,7a'H-
spiro[[1,3]dioxolane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinoline] (32a). To a solution of 
(4a'S,7a'R,12b'S)-9'-(benzyloxy)-3'-(cyclopropylmethyl)-1',2',3',4',5',6'-hexahydro-
4a'H,7a'H-spiro[[1,3]dioxolane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinolin]-4a'-ol 
(250 mg, 0.526 mmol) in DMF (5 mL) was added NaH (60% dispersion in mineral oil) 
(50.5 mg, 2.103 mmol). The reaction mixture was stirred at room temperature for 10 
minutes, followed by the addition of dipropyl sulfate (0.346 mL, 2.103 mmol). After stirring 
at room temperature for 16 h, the reaction mixture was diluted with EtOAc (5 mL) and 
poured into sat. aq. NaHCO3 (10 mL). The organic layer was collected, and the aqueous 
layer extracted with EtOAc (2 × 10 mL). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated. The resulting residue was purified by column chromatography (5-8% EtOAc/Hexanes) to afford 
32a (0.170 g, 0.328 mmol, 62.5%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.44 (m, 2H), 7.37 (m, 2H), 7.31 
(m, 1H), 6.77 (d, J = 8.2 Hz, 1H), 6.56 (d, J = 8.1 Hz, 1H), 5.21 (d, J = 12.0 Hz, 1H), 5.13 (d, J = 12.0 Hz, 1H), 
S3
4.63 (s, 1H), 4.19 (q, 1H), 4.08 (q, 1H), 3.90 (q, 1H), 3.79 (q, 1H), 3.57 (q, 1H), 3.43 (d, J = 4.8 Hz, 1H), 3.21 (q, 
1H), 3.10 (d, J = 18.1 Hz, 1H), 2.67 (m, 1H), 2.60 (td, J = 11.8, 5.3 Hz, 1H), 2.42 – 2.27 (m, 3H), 2.18 (td, J = 
13.5, 2.9 Hz 1H), 2.07 (td, J = 11.6, 4.0 Hz, 1H), 1.78 (dt, J = 13.8, 3.1 Hz, 1H), 1.65 (m, 2H), 1.42 (dt, J = 13.1, 
3.1 Hz, 1H), 1.32 (m, 2H), 1.01 (t, J = 7.4 Hz, 3H), 0.85 (m, 1H), 0.50 (m, 2H), 0.13 (m, 2H). 13C NMR (100 MHz, 
CDCl3) δ 146.7, 141.3, 137.7, 131.8, 128.5 (2C), 127.8, 127.4 (2C), 126.4, 118.0, 115.7, 109.2, 94.1, 74.6, 71.6, 
66.5, 64.9, 60.6, 59.6, 56.1, 48.8, 45.0, 29.8, 28.8, 23.6, 23.3, 23.1, 11.2, 9.5, 3.9, 3.7. 
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-9-hydroxy-4a-propoxy-2,3,4,4a,5,6-hexahydro-1H-4,12-
methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one (20). A solution of 32a (62 mg, 0.120 mmol) in MeOH (2 mL) 
and conc. HCl (1.5 mL) was refluxed for 4 hours. The reaction was cooled to room 
temperature, diluted with water, and treated with 5 N NaOH / solid NH4Cl until pH = 8. The 
product was then extracted using EtOAc (3 × 10 mL). The combined organic extracts were 
dried over Na2SO4, filtered, and concentrated. The resulting residue was purified by column 
chromatography (0-2% MeOH/CH2Cl2) to afford 20 (45 mg, 0.117 mmol, 98.0%) as a light-
yellow solid. 1H NMR (400 MHz, CDCl3) δ 6.69 (d, J = 8.1 Hz, 1H), 6.56 (d, J = 8.1 Hz, 1H), 
4.67 (s, 1H), 3.69 (q, 1H), 3.52 (d, J = 5.3 Hz, 1H), 3.29 (q, 1H), 3.12, (d, J = 18.3 Hz, 1H), 
2.83 (m, 1H), 2.76 – 2.63 (m, 2H), 2.43 – 2.26 (m, 3H), 2.18 (dt, J = 14.7, 3.1 Hz, 1H), 2.14 – 2.00 (m, 2H), 1.68 
(m, 2H), 1.48 – 1.37 (m, 2H), 1.01 (t, J = 7.4 Hz, 3H), 0.86 (m, 1H), 0.51 (m, 2H), 0.13 (m, 2H). 13C NMR (100 
MHz, CDCl3) δ 210.28, 143.62, 138.70, 129.72, 125.52, 119.85, 117.55, 90.88, 75.25, 61.51, 59.74, 56.18, 51.44, 
44.65, 35.81, 29.48, 25.94, 23.69, 23.17, 11.28, 9.52, 4.01, 3.88. HRMS calculated for C23H29NO4 [M+H]+: 
384.2165 (found); 384.2169 (calcd). HPLC purity: 95.95%. 
(4a'S,7a'R,12b'S)-4a'-(allyloxy)-9'-(benzyloxy)-3'-(cyclopropylmethyl)-2',3',4',4a',5',6'-hexahydro-
1'H,7a'H-spiro[[1,3]dioxolane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinoline] (34). To a solution of 
(4a'S,7a'R,12b'S)-9'-(benzyloxy)-3'-(cyclopropylmethyl)-1',2',3',4',5',6'-hexahydro-
4a'H,7a'H-spiro[[1,3]dioxolane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinolin]-4a'-ol 
(1.528 g, 3.213 mmol) in DMF (10 mL) was added NaH (60% dispersion in mineral oil) 
(308 mg, 12.852 mmol). The reaction mixture was stirred at room temperature for 10 
minutes, followed by the addition of allyl bromide (1.10 mL, 12.852 mmol). After stirring 
at room temperature for 16 h, the reaction mixture was diluted with EtOAc (10 mL) and 
poured into sat. aq. NaHCO3 (50 mL). The organic layer was collected, and the aqueous 
layer extracted with EtOAc (2 × 20 mL). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated. The resulting residue was purified by column chromatography (10-20% EtOAc/Hexanes) to afford 
34 (1.260 g, 2.444 mmol, 76.1%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.43 (m, 2H), 7.36 (m, 2H), 7.30 
(m, 1H), 6.75 (d, J = 8.3 Hz, 1H), 6.54 (d, J = 8.1 Hz, 1H), 6.01 (m, 1H), 5.33 (dq, J = 17.1, 1.8 Hz, 1H), 5.19 (d, 
J = 11.9 Hz, 1H), 5.12 (m, 2H), 4.63 (s, 1H), 4.23 – 4.15 (m, 2H), 4.06 (q, J = 6.5 Hz, 1H), 3.88 (m, 1H), 3.84 – 
3.74 (m, 2H), 3.45 (d, J = 4.9 Hz, 1H), 3.09 (d, J = 18.1 Hz, 1H), 2.68 – 2.53 (m, 2H), 2.39 – 2.31 (m, 3H), 2.18 
(td, J = 13.4, 2.9 Hz, 1H), 2.06 (m, 1H), 1.76 (dt, J = 14.1, 3.3 Hz, 1H), 1.44 – 1.28 (m, 3H), 0.83 (m, 1H), 0.48 
(m, 2H), 0.12 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 146.82, 141.43, 137.78, 131.69, 128.56 (2C), 127.88, 127.55 
(2C), 126.35, 118.14, 115.94, 115.19, 109.21, 94.15, 75.53, 71.72, 66.62, 65.04, 60.82, 59.64, 56.20, 48.81, 
45.09, 30.00, 28.94, 23.58, 23.14, 14.33, 9.58, 3.94, 3.85. 
(4R,4aS,7aR,12bS)-4a-(allyloxy)-3-(cyclopropylmethyl)-9-hydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-
methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one (21). A solution of 34 (242 mg, 0.469 mmol) in MeOH (2.5 
mL) and conc. HCl (1.5 mL) was refluxed for 4 hours. The reaction was cooled to room 
temperature, diluted with water, and treated with 5 N NaOH / solid NH4Cl until pH = 8. 
The product was then extracted using EtOAc (3 × 10 mL). The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated. The resulting residue was purified by 
column chromatography (0-2% MeOH/CH2Cl2) to afford 21 (146 mg, 0.383 mmol, 81.6%) 
as a yellow solid. 1H NMR (400 MHz, CDCl3) 6.70 (d, J = 8.2 Hz, 1H), 6.57 (d, J = 8.2 Hz, 
1H), 6.05 (m, 1H), 5.36 (m, 1H), 5.18 (m, 1H), 4.70 (s, 1H), 4.35 (dd, J = 11.8, 4.9 Hz, 
1H), 3.92 (dd, J = 11.8, 5.4 Hz, 1H), 3.55 (d, J = 5.3 Hz, 1H), 3.14 (d, J = 18.3 Hz, 1H), 2.86 (m, 1H), 2.72 (m, 
2H), 2.39 – 2.30 (m, 3H), 2.20 (dt, J = 14.9, 3.1 Hz, 1H), 2.15 – 2.01 (m, 2H), 1.46 (m, 2H), 0.87 (m, 1H), 0.52 
(m, 2H), 0.14 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 209.75, 143.57, 138.67, 135.70, 129.61, 125.42, 119.86, 
S4
117.50, 115.81, 90.84, 76.04, 61.53, 59.66, 56.17, 51.41, 44.70, 35.88, 29.59, 26.08, 23.18, 9.51, 4.01, 3.89. 
HRMS calculated for C23H27NO4 [M+H]+: 382.2019 (found); 382.2013 (calcd). HPLC purity: > 99%. 
3-(((4a'S,7a'R,12b'S)-9'-(benzyloxy)-3'-(cyclopropylmethyl)-1',2',3',4',5',6'-hexahydro-4a'H,7a'H-
spiro[[1,3]dioxolane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinolin]-4a'-yl)oxy)propane-1,2-diol (35). To 
a solution of AD-mix-α (2.335 g; 1.4 g per mmol olefin) in 1:1 tBuOH/H2O (25 mL) was added 
methanesulfonamide (159 mg, 1.668 mmol). The reaction was cooled to 0 °C, followed 
by the addition of 34 (860 mg, 1.668 mmol). After 5 min, the ice bath was removed and 
the solution stirred at room temperature for 16 h. To the resulting yellow suspension was 
added Na2SO3 (2.50 g; 1.5 g per mmol olefin) at 0 °C. The reaction stirred at room 
temperature for 30 min, then basified using 1 N NaOH and extracted with DCM (3 × 20 
mL). The combined organic extracts were dried over Na2SO4, filtered, and concentrated. 
The resulting residue was purified by column chromatography (0-5% MeOH/CH2Cl2) to 
afford 35 (620 mg, 1.128 mmol, 67.6%) as a white solid. 1HMR (400 MHz, CDCl3) δ 7.42 
(m, 2H), 7.36 (m, 2H), 7.30 (m, 1H), 6.77 (d, J = 8.2 Hz, 1H), 6.56 (d, J = 8.2 Hz, 1H), 5.19 (d, J = 11.9 Hz, 1H), 
5.12 (d, J = 12.0 Hz, 1H), 4.63 (s, 1H), 4.18 (m, 1H), 4.05 (m, 1H), 3.96 – 3.86 (m, 2H), 3.77 (m, 2H), 3.58 – 3.45 
(m, 4H), 3.13 (d, J = 18.4 Hz, 1H), 2.91 (dd, J = 12.2, 5.0 Hz, 1H), 2.58 (m, 2H), 2.44 (dd, J = 18.4, 5.2 Hz, 1H), 
2.14 (dd, J = 12.5, 7.6 Hz, 1H), 2.02 (m, 2H), 1.71 (m, 1H), 1.52 – 1.36 (m, 3H), 0.94 (m, 1H), 0.53 (m, 2H), 0.12 
(m, 2H). 13C NMR (100 MHz, CDCl3) δ 146.90, 141.66, 137.61, 130.93, 128.60 (2C), 127.96, 127.54 (2C), 
125.49, 118.25, 116.32, 108.75, 93.81, 75.74, 71.74, 70.61, 66.69, 65.12, 63.56, 63.20, 60.04, 56.14, 48.45, 
44.59, 29.56, 28.78, 24.47, 23.18, 8.41, 5.15, 3.24. 
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a-((R)-2,3-dihydroxypropoxy)-9-hydroxy-2,3,4,4a,5,6-
hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one (22). A solution of 35 (600 mg, 1.092 
mmol) in MeOH (5.5 mL) and conc. HCl (3.0 mL) was refluxed for 4 hours. The reaction was cooled to room 
temperature, diluted with water, and treated with 5 N NaOH / solid NH4Cl until pH = 8. The 
product was then extracted using EtOAc (3 × 15 mL). The combined organic extracts were 
dried over Na2SO4, filtered, and concentrated. The resulting residue was purified by 
column chromatography (0-5% MeOH/CH2Cl2) to afford 22 (420 mg, 1.011 mmol, 92.6%) 
as a white solid. 1H NMR (400 MHz, MeOD) δ 6.63 (d, J = 8.0 Hz, 1H), 6.58 (d, J = 8.2 Hz, 
1H), 4.77 (s, 1H), 3.94 (m, 1H), 3.78 – 3.59 (m, 5H), 3.20 (d, J = 18.7 Hz, 1H), 2.87 (m, 
2H), 2.73 (td, J = 12.4, 5.2 Hz, 1H), 2.54 – 2.42 (m, 2H), 2.29 (dd, J = 12.6, 6.9 Hz, 1H), 
2.20 – 2.04 (m, 3H), 1.46 (m, 2H), 0.98 (m, 1H), 0.54 (m, 2H), 0.18 (m, 2H). 13C NMR (100 MHz, MeOD) δ 211.49, 
145.06, 140.94, 130.35, 125.50, 120.75, 119.10, 91.38, 77.15, 72.17, 64.02, 63.74, 60.51, 56.31, 52.31, 45.69, 
36.18, 30.36, 27.69, 23.68, 8.96, 4.76, 4.18. HRMS calculated for C23H29NO6 [M+H]+: 416.2069 (found); 
416.2068 (calcd). HPLC purity: 98.23%. 
(4aS,7S,7aR,12bS)-9-(benzyloxy)-3-(cyclopropylmethyl)-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-
methanobenzofuro[3,2-e]isoquinoline-4a,7-diol (40a). To a solution of α-naltrexol (410 mg, 1.194 mmol) in 
DMF (9.5 mL) was added K2CO3 (495 mg, 3.582 mmol) and benzyl bromide (0.14 mL, 
1.194 mmol). After stirring at room temperature for 16 h, the reaction mixture was poured 
into water (200 mL) and extracted with EtOAc (3 × 150 mL). The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated. The resulting residue was purified by 
column chromatography (0-5% MeOH/CH2Cl2) to afford 40a (480 mg, 1.107 mmol, 92.7%) 
as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.42 (m, 2H), 7.36 (m, 2H), 7.30 (m, 1H), 
6.77 (d, J = 8.2 Hz, 1H), 6.55 (d, J = 8.2 Hz, 1H), 5.23 (d, J = 12.2 Hz, 1H), 5.12 (d, J = 12.2 Hz, 1H), 4.62 (m, 
1H), 4.15 (m, 1H), 3.10 – 2.96 (m, 2H), 2.60 (m, 2H), 2.34 (m, 2H), 2.22 (m, 2H), 1.72 (m, 1H), 1.66 – 1.40 (m, 
3H), 1.07 (m, 1H), 0.84 (m, 1H), 0.53 (m, 2H), 0.11 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 147.14, 140.50, 
137.65, 132.07, 128.64 (2C), 128.04, 127.53 (2C), 126.92, 119.05, 117.06, 90.87, 72.14, 69.87, 66.84, 62.25, 




methanobenzofuro[3,2-e]isoquinolin-4a-ol (37a). To a solution of 40a (465 mg, 1.073 mmol) in THF (10 mL) 
was added NaH (60% dispersion in mineral oil) (46 mg, 1.931 mmol) and iodomethane (0.073 mL, 1.180 mmol). 
The reaction stirred at room temperature for 16 h, then poured into water (20 mL) and 
extracted with EtOAc (3 × 20 mL). The combined organic extracts were dried over Na2SO4, 
filtered, and concentrated. The resulting residue was purified by column chromatography 
(0-2% MeOH/CH2Cl2) to afford 37a (370 mg, 0.827 mmol, 77.1%) as a clear oil. 1H NMR 
(400 MHz, CDCl3) δ 7.45 (m, 2H), 7.33 (m, 2H), 7.28 (m, 1H), 6.72 (d, J = 8.1 Hz, 1H), 
6.48 (d, J = 8.2 Hz, 1H), 5.21 (dd, J = 12.1, 4.9 Hz, 2H), 4.78 (d, J = 4.4 Hz, 1H), 3.82 (dt, J = 10.7, 4.1 Hz, 1H), 
3.46 (s, 3H), 3.07 (d, J = 6.5 Hz, 1H), 3.02 (d, J = 18.5 Hz, 1H), 2.65 – 2.54 (m, 2H), 2.34 (m, 2H), 2.24 (m, 2H), 
1.75 (m, 1H), 1.67 – 1.55 (m, 2H), 1.47 (m, 1H), 1.24 (m, 1H), 0.85 (m, 1H), 0.53 (m, 2H), 0.13 (m, 2H). 13C NMR 
(100 MHz, CDCl3) δ 148.08, 140.58, 137.84, 131.72, 128.45 (2C), 127.78 (2C), 127.77, 126.68, 118.27, 117.43, 
88.71, 75.98, 71.94, 70.09, 62.31, 59.64, 57.32, 47.24, 43.43, 33.60, 28.70, 22.96, 20.64, 9.51, 4.07, 3.90. 
 
(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-7-methoxy-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-
methanobenzofuro[3,2-e]isoquinoline-4a,9-diol (25). To a solution of 37a (280 mg, 0.626 mmol) in THF (11 
mL) was added Palladium on Carbon (5 wt. % loading) (100 mg). The reaction flask was 
capped with a rubber septum and flushed with H2. The reaction stirred at room 
temperature under an H2 balloon for 16 h. The reaction mixture was then filtered through 
Celite, rinsing with EtOAc, and concentrated. The resulting residue was purified by column 
chromatography (5% MeOH/CH2Cl2) to afford 25 (208 mg, 0.582 mmol, 93.0%) as a white 
foam. 1H NMR (400 MHz, CDCl3) δ 6.70 (d, J = 8.1 Hz, 1H), 6.51 (d, J = 8.2 Hz, 1H), 4.76 
(d, J = 3.3 Hz, 1H), 3.84 (dt, J = 12.1, 4.1 Hz, 1H), 3.46 (s, 3H), 3.08 (d, J = 6.8 Hz, 1H), 3.03 (d, J = 18.5 Hz, 
1H), 2.64 (m, 1H), 2.58 (m, 1H), 2.34 (m, 2H), 2.25 (m, 2H), 1.76 – 1.56 (m, 3H), 1.45 (m, 1H), 1.12 (m, 1H), 
0.84 (m, 1H), 0.54 (m, 2H), 0.13 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 145.98, 137.62, 130.83, 125.43, 118.81, 
117.44, 88.87, 76.02, 70.13, 62.19, 59.67, 57.02, 47.75, 43.28, 33.76, 29.11, 22.93, 19.77, 9.46, 4.07, 3.86. 
HRMS calculated for C21H27NO4 [M+H]+: 358.2012 (found); 358.2013 (calcd). HPLC purity: 95.38%. 
 
(4aS,7R,7aR,12bS)-9-(benzyloxy)-3-(cyclopropylmethyl)-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-
methanobenzofuro[3,2-e]isoquinoline-4a,7-diol (40b). To a solution of β-naltrexol (510 mg, 1.485 mmol) in 
DMF (12.0 mL) was added K2CO3 (616 mg, 4.455 mmol) and benzyl bromide (0.18 mL, 
1.485 mmol). After stirring at room temperature for 16 h, the reaction mixture was poured 
into water (200 mL) and extracted with EtOAc (3 × 150 mL). The combined organic 
extracts were dried over Na2SO4, filtered, and concentrated. The resulting residue was 
purified by column chromatography (0-5% MeOH/CH2Cl2) to afford 40b (530 mg, 1.222 
mmol, 82.3%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.38 (m, 2H), 7.30 (m, 2H), 7.25 (m, 1H), 6.73 (d, J = 
8.2 Hz, 1H), 6.53 (d, J = 8.2 Hz, 1H), 5.18 (d, J = 12.1 Hz, 1H), 5.11 (d, J = 12.1 Hz, 1H), 4.43 (d, J = 5.8 Hz, 
1H), 3.45 (m, 1H), 3.05 (d, J = 5.8 Hz, 1H), 2.98 (d, J = 18.5 Hz, 1H), 2.56 (m, 2H), 2.32 (d, J = 6.5 Hz, 2H), 2.20 
(td, J = 12.5, 5.0 Hz, 1H), 2.08 (td, J = 12.0, 3.5 Hz, 1H), 1.90 (m, 1H), 1.58 (dt, J = 13.3, 4.2 Hz, 1H), 1.52 (dt, 
J = 13.1, 4.4 Hz, 1H), 1.45 (m, 1H), 1.29 (m, 1H), 0.81 (m, 1H), 0.50 (m, 2H), 0.09 (m, 2H). 13C NMR (100 MHz, 
CDCl3) δ 144.67, 142.21, 137.57, 132.35, 128.42 (2C), 127.84, 127.57 (2C), 126.06, 118.66, 116.97, 95.68, 
72.10, 71.85, 70.13, 62.20, 59.31, 47.00, 43.77, 31.35, 29.26, 25.34, 22.75, 9.46, 3.95, 3.85. 
 
(4aS,7R,7aR,12bS)-9-(benzyloxy)-3-(cyclopropylmethyl)-7-methoxy-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-
methanobenzofuro[3,2-e]isoquinolin-4a-ol (37b). To a solution of 40b (470 mg, 1.084 mmol) in THF (10 mL) 
was added NaH (60% dispersion in mineral oil) (47 mg, 1.951 mmol) and iodomethane 
(0.074 mL, 1.192 mmol). The reaction stirred at room temperature for 16 h, then poured 
into water (20 mL) and extracted with EtOAc (3 × 20 mL). The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated. The resulting residue was purified 
by column chromatography (0-2% MeOH/CH2Cl2) to afford 37b (360 mg, 0.804 mmol, 
74.2%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.41 (m, 2H), 7.33 (m, 2H), 7.28 (m, 
1H), 6.74 (d, J = 8.1 Hz, 1H), 6.54 (d, J = 8.2 Hz, 1H), 5.20 (s, 2H), 4.51 (d, J = 6.3 Hz, 1H), 3.45 (s, 3H), 3.10 
(m, 2H), 2.99 (d, J = 18.3 Hz, 1H), 2.58 (m, 2H), 2.34 (d, J = 6.5 Hz, 2H), 2.22 (td, J = 12.5, 5.2 Hz, 1H), 2.06 
(td, J = 12.2, 3.7 Hz, 1H), 1.87 (m, 1H), 1.78 (m, 1H), 1.58 (m, 1H), 1.45 (m, 1H), 1.33 (td, J = 13.5, 3.3 Hz, 1H), 
0.81 (m, 1H), 0.51 (m, 2H), 0.10 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 144.61, 142.57, 137.72, 132.70, 128.51 
S6
 
(2C), 127.90, 127.66 (2C), 126.05, 118.58, 117.64, 95.13, 82.10, 72.17, 70.15, 62.40, 59.30, 57.64, 47.67, 43.98, 
30.81, 29.69, 23.56, 22.81, 9.57, 4.03, 3.91. 
 
(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-7-methoxy-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-
methanobenzofuro[3,2-e]isoquinoline-4a,9-diol (26). To a solution of 37b (300 mg, 0.670 mmol) in THF (12 
mL) was added Palladium on Carbon (5 wt. % loading) (100 mg). The reaction flask was 
capped with a rubber septum and flushed with H2. The reaction stirred at room 
temperature under an H2 balloon for 16 h. The reaction mixture was then filtered through 
Celite, rinsing with EtOAc, and concentrated. The resulting residue was purified by 
column chromatography (5% MeOH/CH2Cl2) to afford 26 (212 mg, 0.593 mmol, 88.5%) 
as a white solid. 1H NMR (400 MHz, CDCl3) δ 6.71 (d, J = 8.1 Hz, 1H), 6.56 (d, J = 8.2 
Hz, 1H), 4.52 (d, J = 6.4 Hz, 1H), 3.43 (s, 3H), 3.09 (m, 2H), 3.01 (d, J = 18.3 Hz, 1H), 2.60 (m, 2H), 2.36 (d, J = 
6.6 Hz, 2H), 2.24 (td, J = 12.4, 5.0 Hz, 1H), 2.10 (td, J = 12.0, 3.7 Hz, 1H), 1.85 (m, 2H), 1.62 (dt, J = 13.4, 3.4 
Hz, 1H), 1.45 (m, 1H), 1.33 (m, 1H), 0.83 (m, 1H), 0.52 (m, 2H), 0.12 (m, 2H). 13C NMR (100 MHz, CDCl3) 
δ 142.32, 139.47, 131.94, 124.82, 118.99, 116.72, 95.51, 82.18, 70.33, 62.45, 59.34, 57.23, 48.03, 44.03, 30.72, 
29.67, 23.04, 22.78, 9.60, 4.07, 3.94. HRMS calculated for C21H27NO4 [M+H]+: 358.2015 (found); 358.2013 
(calcd). HPLC purity: 96.95%. 
 
(4aS,7aS,12bS)-9-(benzyloxy)-3-(cyclopropylmethyl)-7-methylene-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-
methanobenzofuro[3,2-e]isoquinolin-4a-ol (38). To a suspension of methyltriphenylphosphonium bromide 
(14.869 g, 3.896 mmol) in THF (30 mL) was added tBuOK (5.072 g, 45.196 mmol) in 
portions over a minute. The resulting yellow suspension stirred at room temperature for 
30 minutes, then a solution of (4aS,7aR,12bS)-9-(benzyloxy)-3-(cyclopropylmethyl)-4a-
hydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-
one (4.610 g, 10.684 mmol) in THF (10 mL) was added dropwise. The reaction stirred at 
room temperature for 16 h under a nitrogen atmosphere. The reaction mixture was 
poured into sat. aq. NH4Cl (40 mL) and extracted with EtOAc (3 × 40 mL). The combined organic extracts were 
washed with water, dried over Na2SO4, filtered, and concentrated. The resulting residue was purified by 
column chromatography (20% EtOAc/Hexanes) to afford 38 (3.730 g, 8.683 mmol, 81.3 %) as a light-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.45 (m, 2H), 7.36 (m, 2H), 7.30 (m, 1H), 6.77 (d, J = 8.1 Hz, 1H), 6.56 (d, J = 8.1 
Hz, 1H), 5.32 (q, J = 2.0 Hz, 1H), 5.19 (m, 2H), 5.03 (q, J = 1.9 Hz, 1H), 4.89 (q, J = 2.0 Hz, 1H), 3.06 (d, J = 
5.8 Hz, 1H), 3.01 (d, J = 18.3 Hz, 1H), 2.70 – 2.52 (m, 3H), 2.37 (d, J = 6.6 Hz, 2H), 2.31 (td, J = 12.5, 5.2 Hz, 
1H), 2.15 (m, 2H), 1.63 (dt, J = 12.9, 3.6 Hz, 1H), 1.53 (dd, J = 12.5, 3.8 Hz, 1H), 1.37 (td, J = 13.2, 3.7 Hz, 
1H), 0.86 (m, 1H), 0.54 (m, 2H), 0.14 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 145.79, 145.37, 142.20, 137.71, 
131.70, 128.51 (2C), 127.87, 127.65 (2C), 127.05, 118.63, 116.95, 111.45, 89.48, 72.00, 70.92, 62.67, 59.31, 
48.56, 44.43, 32.38, 30.63, 28.35, 22.84, 9.58, 4.04, 3.90.  
 
(4aS,7aS,12bS)-4a-(allyloxy)-9-(benzyloxy)-3-(cyclopropylmethyl)-7-methylene-2,3,4,4a,5,6,7,7a-
octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline (39a). To a solution of 38 (1.032 g, 2.402 mmol) in 
DMF (10 mL) was added NaH (60% dispersion in mineral oil) (231 mg, 9.610 mmol). The 
reaction mixture was stirred at room temperature for 10 minutes, followed by the addition 
of allyl bromide (0.83 mL, 9.610 mmol). After stirring at room temperature for 16 h, the 
reaction mixture was diluted with EtOAc (10 mL) and poured into sat. aq. NaHCO3 (50 mL). 
The organic layer was collected, and the aqueous layer extracted with EtOAc (2 × 20 mL). 
The combined organic extracts were dried over Na2SO4, filtered, and concentrated. The 
resulting residue was purified by column chromatography (5-8% EtOAc/Hexanes) to afford 
39a (0.900 g, 1.916 mmol, 79.8%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.45 (m, 2H), 7.36 (m, 2H), 7.31 
(m, 1H), 6.72 (d, J = 8.2 Hz, 1H), 6.53 (d, J = 8.1 Hz, 1H), 6.04 (m, 1H), 5.39 – 5.30 (m, 2H), 5.20 (m, 2H), 5.15 
(dq, J = 10.4, 1.9 Hz, 1H), 5.06 (m, 1H), 4.85 (m, 1H), 4.25 (dd, J = 12.2, 2.1 Hz, 1H), 3.87 (dd, J = 12.0, 2.1 Hz, 
1H), 3.43 (d, J = 5.2 Hz, 1H), 3.09 (d, J = 18.2 Hz, 1H), 2.72 – 2.50 (m, 3H), 2.35 (m, 3H), 2.12 – 1.97 (m, 2H), 
1.80 (dq, J = 13.8, 3.1 Hz, 1H), 1.40 (dt, J = 12.3, 2.5 Hz, 1H), 1.18 (m, 1H), 0.86 (m, 1H), 0.50 (m, 2H), 0.13 
(m, 2H). 13C NMR (100 MHz, CDCl3) δ 145.97, 145.39, 142.24, 137.82, 136.29, 132.23, 128.54 (2C), 127.87, 
127.71 (2C), 127.19, 118.51, 116.80, 115.18, 111.76, 89.60, 76.62, 72.06, 60.97, 59.69, 56.46, 49.05, 45.51, 





methanobenzofuro[3,2-e]isoquinolin-9-ol (28). A solution of 39a (340 mg, 0.724 mmol) in MeOH (3.0 mL) and 
conc. HCl (2.0 mL) was refluxed for 4 hours. The reaction was cooled to room temperature, 
diluted with water, and treated with 5 N NaOH / solid NH4Cl until pH = 8. The product was 
then extracted using EtOAc (3 × 10 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated. The resulting residue was purified by column 
chromatography (0-20% EtOAc/Hexanes) to afford 28 (155 mg, 0.408 mmol, 56.4%) as a 
light yellow solid. 1H NMR (400 MHz, CDCl3) δ 6.66 (d, J = 8.2 Hz, 1H), 6.53 (d, J = 8.1 Hz, 
1H), 6.03 (m, 1H), 5.34 (dq, J = 17.2, 1.8 Hz, 1H), 5.24 (q, J = 1.9 Hz, 1H), 5.14 (dq, J = 
10.4, 1.5 Hz, 1H), 5.06 (m, 1H), 4.83 (m, 1H), 4.24 (dd, J = 12.1, 4.2 Hz, 1H), 3.85 (m, 1H), 3.43 (d, J = 5.3 Hz, 
1H), 3.09 (d, J = 18.1 Hz, 1H), 2.70 (m, 1H), 2.65 – 2.48 (m, 2H), 2.37 – 2.29 (m, 3H), 2.09 (m, 1H), 2.00 (m, 
1H), 1.79 (dt, J = 13.8, 3.6 Hz, 1H), 1.38 (m, 1H), 1.15 (td, J = 13.5, 3.7 Hz, 1H), 0.85 (m, 1H), 0.49 (m, 2H), 
0.12 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 145.80, 143.15, 138.91, 136.27, 131.60, 126.09, 118.97, 116.27, 
115.19, 111.60, 90.33, 76.69, 61.00, 59.69, 56.49, 49.37, 45.51, 29.31, 27.86, 26.57, 23.23, 9.57, 4.01, 3.83. 
HRMS calculated for C24H29NO3 [M+H]+: 380.2220 (found); 380.2220 (calcd). HPLC purity: 97.73%. 
 
(4aS,7aS,12bS)-9-(benzyloxy)-3-(cyclopropylmethyl)-7-methylene-4a-propoxy-2,3,4,4a,5,6,7,7a-
octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline (39b). To a solution of 38 (340 mg, 0.792 mmol) in 
DMF (5 mL) was added NaH (60% dispersion in mineral oil) (76.0 mg, 3.166 mmol). The 
reaction mixture was stirred at room temperature for 10 minutes, followed by the addition 
of dipropyl sulfate (0.520 mL, 3.166 mmol). After stirring at room temperature for 16 h, the 
reaction mixture was diluted with EtOAc (5 mL) and poured into sat. aq. NaHCO3 (10 mL). 
The organic layer was collected, and the aqueous layer extracted with EtOAc (2 × 10 mL). 
The combined organic extracts were dried over Na2SO4, filtered, and concentrated. The 
resulting residue was purified by column chromatography (5-10% EtOAc/Hexanes) to afford 
39b (0.170 g, 0.360 mmol, 45.5%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.44 (m, 2H), 7.35 (m, 2H), 7.30 
(m, 1H), 6.71 (d, J = 8.2 Hz, 1H), 6.52 (d, J = 7.9 Hz, 1H), 5.31 (q, J = 2.0 Hz, 1H), 5.19 (m, 2H), 5.03 (q, J = 1.9 
Hz, 1H), 4.84 (q, J = 2.0 Hz, 1H), 3.58 (m, 1H), 3.40 (d, J = 5.1 Hz, 1H), 3.22 (m, 1H), 3.07, (d, J = 18.2 Hz, 1H), 
2.68 (dd, J = 11.4, 5.1 Hz, 1H), 2.63 – 2.48 (m, 2H), 2.38 – 2.26 (m, 3H), 2.09 – 1.95 (m, 2H), 1.80 (m, 1H), 1.63 
(m, 2H), 1.37 (m, 1H), 1.13 (t, J = 13.5 Hz, 1H), 0.99 (td, J = 7.4, 2.0 Hz, 3H), 0.84 (m, 1H), 0.49 (m, 2H), 0.11 
(m, 2H). 13C NMR (100 MHz, CDCl3) δ 146.25, 145.41, 142.20, 137.87, 132.39, 128.54 (2C), 127.87, 127.73 
(2C), 127.39, 118.48, 116.67, 111.57, 89.71, 75.79, 72.05, 60.94, 59.80, 56.48, 49.09, 45.49, 29.29, 27.87, 
26.52, 23.77, 23.27, 11.32, 9.60, 3.97, 3.87.  
 
(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-4a-propoxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-
methanobenzofuro[3,2-e]isoquinolin-9-ol (29). A solution of 39b (170 mg, 0.360 mmol) in MeOH (2.0 mL) and 
conc. HCl (1.5 mL) was refluxed for 4 hours. The reaction was cooled to room temperature, diluted with water, 
and treated with 5 N NaOH / solid NH4Cl until pH = 8. The product was then extracted using 
EtOAc (3 × 10 mL). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated. The resulting residue was purified by column chromatography (0-2% MeOH/ 
CH2Cl2) to afford 29 (102 mg, 0.267 mmol, 74.2%) as a yellow solid. 1H NMR (400 MHz, 
CDCl3) δ 6.66 (d, J = 8.1 Hz, 1H), 6.52 (d, J = 8.1 Hz, 1H), 5.24 (m, 1H), 5.03 (m, 1H), 4.82 
(m, 1H), 3.58 (m, 1H), 3.40 (d, J = 5.2 Hz, 1H), 3.22 (m, 1H), 3.07 (d, J = 18.2 Hz, 1H), 2.69 
(dd, J = 11.5, 5.2 Hz, 1H), 2.64 – 2.45 (m, 2H), 2.39 – 2.27 (m, 3H), 2.09 (m, 1H), 1.98 (dt, J = 13.8, 3.5 Hz, 1H), 
1.79 (dt, J = 13.7, 3.6 Hz, 1H), 1.63 (m, 2H), 1.35 (dd, J = 11.8, 3.8 Hz, 1H), 1.10 (m, 1H), 0.98 (t, J = 7.4, 1.0 
Hz, 3H), 0.86 (m, 1H), 0.48 (m, 2H), 0.11 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 145.99, 143.12, 138.93, 131.71, 
126.16, 118.98, 116.25, 111.43, 90.40, 75.84, 60.98, 59.76, 56.49, 49.38, 45.48, 29.17, 27.79, 26.42, 23.74, 
23.23, 11.29, 9.54, 3.94, 3.90. HRMS calculated for C24H31NO3 [M+H]+: 382.2381 (found); 382.2377 (calcd). 





1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one (41). To a solution of 22 (410 mg, 0.987 mmol) in 
DMF (8.0 mL) was added K2CO3 (273 mg, 1.974 mmol) and benzyl bromide (0.13 mL, 1.085 mmol). After stirring 
at room temperature for 16 h, the reaction mixture was poured into water (100 mL) and 
extracted with EtOAc (3 × 100 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated. The resulting residue was purified by column 
chromatography (0-3% MeOH/CH2Cl2) to afford 41 (426 mg, 0.843 mmol, 85.4%) as a 
light-yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.44 (m, 2H), 7.33 (m, 2H), 7.27 (m, 1H), 6.71 
(d, J = 8.2 Hz, 1H), 6.55 (d, J = 8.2 Hz, 1H), 5.26 (d, J = 12.0 Hz, 1H), 5.20 (d, J = 12.0 
Hz, 1H), 4.71 (s, 1H), 4.67 (s, 1H), 3.99 (m, 1H), 3.77 (dd, J = 11.4, 4.6 Hz, 1H), 3.69 – 
3.53 (m, 3H), 3.15 (d, J = 18.7 Hz, 1H), 2.94 (m, 1H), 2.73 (m, 2H), 2.53 (dd, J = 12.5, 5.4 Hz, 1H), 2.41 (dd, J = 
18.8, 5.5 Hz, 1H), 2.28 – 2.14 (m, 2H), 2.01 (m, 2H), 1.52 (m, 2H), 0.95 (m, 1H), 0.55 (m, 2H), 0.12 (m, 2H). 13C 
NMR (100 MHz, CDCl3) δ 207.70, 145.64, 142.04, 137.45, 128.47 (2C), 127.89, 127.84 (2C), 127.02, 125.70, 
119.51, 118.24, 90.34, 76.13, 72.18, 70.60, 63.78, 63.44, 59.94, 55.81, 50.85, 44.15, 35.48, 29.09, 26.98, 23.11, 
8.29, 5.02, 3.30. 
 
3-(((4aS,7aS,12bS)-9-(benzyloxy)-3-(cyclopropylmethyl)-7-methylene-1,2,3,4,5,6,7,7a-octahydro-4aH-
4,12-methanobenzofuro[3,2-e]isoquinolin-4a-yl)oxy)propane-1,2-diol (39c). To a suspension of 
methyltriphenylphosphonium bromide (1.156 g, 3.236 mmol) in THF (4.0 mL) was added 
tBuOK (395 mg, 3.514 mmol) in portions over a minute. The resulting yellow suspension 
stirred at room temperature for 30 minutes, then a solution of 41 (420 mg, 0.831 mmol) in 
THF (2 mL) was added dropwise. The reaction stirred at room temperature for 16 h under 
a nitrogen atmosphere. The reaction mixture was poured into sat. aq. NH4Cl (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with water 
(8 mL), dried over Na2SO4, filtered, and concentrated. The resulting residue was purified 
by column chromatography (0-5% MeOH/CH2Cl2) to afford 39c (72 mg, 0.143 mmol, 
17.2%) as a yellow foam. 1HMR (400 MHz, CDCl3) δ 7.43 (m, 2H), 7.35 (m, 2H), 7.30 (m, 1H), 6.74 (d, J = 8.2 
Hz, 1H), 6.54 (d, J = 8.2 Hz, 1H), 5.33 (m, 1H), 5.19 (s, 2H), 5.05 (m, 1H), 4.88 (m, 1H), 3.96 (m, 1H), 3.78 (dd, 
J = 11.5, 4.3 Hz, 1H), 3.62 – 3.53 (m, 3H), 3.50 (d, J = 5.2 Hz, 1H), 3.12 (d, J = 18.5 Hz, 1H), 2.98 (dd, J = 12.0, 
4.9 Hz, 1H), 2.67 – 2.37 (m, 3H), 2.19 (dd, J = 12.5, 7.6 Hz, 1H), 2.12 – 1.96 (m, 2H), 1.77 (m, 1H), 1.49 (dd, J 
= 12.5, 3.9 Hz, 1H), 1.25 (m, 2H), 0.96 (m, 1H), 0.54 (m, 2H), 0.14 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 145.42, 
144.92, 142.55, 137.62, 133.18, 131.31, 128.58 (2C), 127.96, 127.68 (2C), 126.00, 118.70, 117.16, 112.27, 
89.25, 72.04, 70.79, 63.63, 63.39, 60.03, 56.51, 48.67, 45.04, 28.77, 27.64, 27.55, 23.33, 8.28, 5.16, 3.31. 
 
(R)-3-(((4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-9-hydroxy-7-methylene-1,2,3,4,5,6,7,7a-octahydro-4aH-
4,12-methanobenzofuro[3,2-e]isoquinolin-4a-yl)oxy)propane-1,2-diol (30). A solution of 29c (47 mg, 0.093 
mmol) in MeOH (2.0 mL) and conc. HCl (1.5 mL) was refluxed for 4 hours. The reaction 
was cooled to room temperature, diluted with water, and treated with 5 N NaOH / solid 
NH4Cl until pH = 8. The product was then extracted using EtOAc (3 × 10 mL). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated. The 
resulting residue was purified by column chromatography (0-10% MeOH/CH2Cl2) to afford 
30 (25 mg, 0.060 mmol, 64.8%) as a light brown solid. 1H NMR (400 MHz, MeOD) δ 6.60 
(d, J = 8.1 Hz, 1H), 6.53 (d, J = 8.1 Hz, 1H), 5.31 (q, J = 2.0 Hz, 1H), 4.98 (q, J = 1.9 Hz, 
1H), 4.84 (q, J = 2.2 Hz, 1H), 3.92 (m, 1H), 3.71 (d, J = 5.4 Hz, 1H), 3.67 – 3.55 (m, 4H), 
3.21 (s, 1H), 2.95 (dd, J = 12.3, 4.9 Hz, 1H), 2.67 – 2.42 (m, 4H), 2.35 (dd, J = 12.7, 7.3 Hz, 1H), 2.13 (m, 2H), 
1.86 (dt, J = 13.9, 3.4 Hz, 1H), 1.45 (m, 1H), 1.21 (m, 1H), 1.00 (m, 1H), 0.56 (m, 2H), 0.22 (m, 2H). 13C NMR 
(100 MHz, MeOD) δ 146.81, 144.84, 141.54, 134.96, 131.67, 124.96, 119.83, 118.25, 111.93, 90.02, 77.93, 
72.29, 64.05, 63.63, 60.50, 57.32, 49.92, 46.48, 29.74, 28.41, 23.98, 8.57, 5.03, 4.08. HRMS calculated for 
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